Cytosine Arabinoside Promotes Cytotoxic Effect of T Cells on Leukemia Cells Mediated by Bispecific Antibody-Reference-Cited by-同舟云学术

Cytosine Arabinoside Promotes Cytotoxic Effect of T Cells on Leukemia Cells Mediated by Bispecific Antibody

Published:2013-08 Issue:8 Volume:24 Page:751-760
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Li Wei¹²,Fan DongMei¹,Yang Ming¹,Yan Yan¹,Shi RuiZan³,Cheng JunPing²,Li ZhenZhen¹,Zhang MengNan¹,Wang JianXiang¹,Xiong DongSheng¹

Affiliation:

1. State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China.

2. Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.

3. Department of Pharmacology, Shanxi Medical University, Shanxi 030001, P.R. China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2013.051

Reference38 articles.

1. CD28-B7 interactions in T-cell activation

2. Low-Dose Combretastatin A4 Phosphate Enhances the Immune Response of Tumor Hosts to Experimental Colon Carcinoma

3. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

4. Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group

5. The Role of CTLA-4 in the Regulation and Initiation of T-Cell Responses

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy;Experimental Hematology & Oncology;2023-07-24

2. 4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling;Science Signaling;2020-03-31

3. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells;Journal of Hematology & Oncology;2015-10-06

4. T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330;Blood Cancer Journal;2015-08

5. New insights into metronomic chemotherapy-induced immunoregulation;Cancer Letters;2014-11